 |
Cytarabine:daunorubicin liposome injection |
|---|---|
| Trade Name | Vyxeos |
| Orphan Indication | Acute myeloid leukemia |
| USA Market Approval | USA |
| USA Designation Date | 2008-08-22 00:00:00 |
| Sponsor | Celator Pharmaceuticals, Inc.;200 Princeton South Corporate Center, Suite 180;Ewing, New Jersey, 08628 |
